Breaking Down Shanghai Chicmax Cosmetic Co., Ltd. Financial Health: Key Insights for Investors

Dive into a data-driven look at Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK), where top-line momentum is unmistakable-annual revenue surged by 62.08% to CN¥6.79 billion in 2024 and Q2 2025 revenue rose 24.86% year-over-year to CN¥4.11 billion-yet beneath that growth lie signals investors must weigh, from a net income of CN¥781.21 million in 2024 (up 69.42%) and a market capitalization of HK$33.60 billion to a concerning accrual ratio of 0.27 and CN¥52 million in unusual items; throw in a conservative debt-to-equity ratio of 0.12, a net cash position of CN¥546.86 million, a forward P/E of 27.81, P/S of 4.12 and P/B of 12.17, and you have a complex mix of strong cash generation (operating cash flow CN¥783.82 million, free cash flow CN¥518.37 million) and risks around earnings quality, competition and regulation-read on to unpack what these figures mean for valuation, liquidity, leverage and the growth runway analysts forecast (approximately 18% annual revenue growth) and decide whether Chicmax fits your portfolio.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Revenue Analysis

• Annual revenue (2024): CN¥6.79 billion (+62.08% vs. 2023)
• Annual revenue (2023): CN¥4.19 billion
• Q2 2025 revenue: CN¥4.11 billion (+24.86% vs. Q2 2024)
• Market capitalization (12 Dec 2025): HK$33.60 billion
• Employees: 2,086; revenue per employee ≈ CN¥3.55 million
• Analyst three‑year revenue CAGR forecast: ~18% p.a.

• Skincare - core margin and growth driver
• Maternity & childcare - stable recurring demand
• Washing & personal care - volume and shelf presence
• Makeup - brand extension and cross‑sell opportunities

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Profitability Metrics

• Net income (2024): CN¥781.21 million (↑69.42% vs CN¥461.10 million in 2023)
• Trailing twelve months (TTM) EPS: CN¥2.49
• Forward P/E: 27.81
• Profit margin (2024): 12% (stable vs 2023)
• Accrual ratio: 0.27 - indicates free cash flow lagging reported profits
• Unusual items: CN¥52 million boosted 2024 profit (potentially non-recurring)
• Dividend yield: 1.32%; interim dividend declared Sep 2025: CN¥0.50 per share

• Quality of earnings: accrual ratio 0.27 signals that a meaningful portion of 2024 earnings may not have converted into free cash flow; investors should reconcile net income to operating cash flow.
• One-off effects: CN¥52m of unusual items materially lifted reported profit - adjust pro forma earnings to assess sustainable profitability.
• Valuation vs growth: forward P/E of 27.81 combined with EPS TTM CN¥2.49 implies the market is paying for continued earnings growth; confirm with cash generation trends.
• Income return: 1.32% dividend yield and interim CN¥0.50/share provide modest income; dividend sustainability depends on cash flow conversion and recurrence of exceptional items.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Debt vs. Equity Structure

• Total Debt: CN¥329.64 million - modest absolute debt outstanding.
• Equity (Book Value): CN¥2.74 billion - substantial shareholder capital backing.
• Debt-to-Equity Ratio: ~0.12 - low financial leverage relative to equity.
• Net Cash Position: CN¥546.86 million - company holds more cash than interest-bearing debt.
• Book Value per Share: CN¥6.69 - meaningful per-share equity cushion.
• Capital Structure: Balanced with low reliance on debt financing, enabling strategic optionality.

• Investor implications: low leverage reduces default and interest-rate risks while preserving capacity for opportunistic M&A or capex funded from cash rather than new debt.
• Capital allocation flexibility: positive net cash and sizable equity allow dividends, buybacks, or reinvestment without immediate financing pressure.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Liquidity and Solvency

Key liquidity and solvency metrics for Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) show ample short-term liquidity and solid long-term solvency, underpinned by strong operating cash generation and disciplined capital spending.

• Cash reserves of CN¥660.91M provide a buffer for operational volatility and short-term commitments.
• Working capital of CN¥1.47B reflects healthy operating liquidity to fund receivables, inventory and payables.
• Operating cash flow of CN¥783.82M and free cash flow of CN¥518.37M demonstrate strong cash generation after reinvestment.
• CapEx of CN¥265.45M shows continued investment into production, R&D, or expansion while preserving free cash flow.
• Solvency ratios (Current 2.3x, Quick 1.8x, Debt-to-Equity 0.42x, Interest Coverage 8.5x) signal a strong ability to meet both short- and long-term obligations.

For alignment with corporate direction and investor context, see: Mission Statement, Vision, & Core Values (2026) of Shanghai Chicmax Cosmetic Co., Ltd.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Valuation Analysis

• Market Capitalization: HK$33.60 billion - a market-sized indicator of investor confidence and scale.
• Price-to-Sales (P/S): 4.12 - suggests the market values each HK$1 of revenue at ~HK$4.12.
• Price-to-Book (P/B): 12.17 - implies a significant premium over reported book equity.
• Earnings Yield: 2.97% - inverse of P/E, showing modest earnings per dollar invested.
• Dividend Yield: 1.32% - provides a small recurring cash return to shareholders.
• Analyst Consensus: Strong Buy; average price target HK$110.85 - indicates projected upside from current levels.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Risk Factors

This chapter breaks down the primary risk drivers that can materially affect the financial health and investor outlook for Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK), using key measurable indicators and contextual industry figures.

• Earnings Quality: High accruals, non-recurring items, and margin volatility

Key metrics (recent fiscal year):

• Implications: A low OCF/Net income ratio (<1x) and a material share of one-off gains increase the risk that reported profits are not fully sustainable. Investors should watch for repeated inventory write-downs, changes in allowance policies, or one-time fair-value adjustments.

• Market Competition: Intense domestic and international rivalry

Contextual data:

• Implications: Price promotions, channel expansion by multinationals, and rapid DTC/online innovation can compress margins and require ongoing marketing and R&D spend to defend share.

• Regulatory Changes: Product safety, labeling, and import/export rules

Relevant considerations:

• Cosmetic product registration timelines: can range from 30 days (for general cosmetics) to 90-180+ days for regulated products in some jurisdictions.
• Potential compliance costs: estimated incremental capex/OPEX of 1%-3% of revenue in a year with major regulatory updates.

• Supply Chain Disruptions: Raw material concentration and logistics exposure

Observed dependencies and sensitivities:

• Proportion of COGS from petrochemical-derived raw materials and active ingredients: often 40%-60% of direct materials cost, which are price-volatile.
• Single/limited-supplier reliance: if 1-2 suppliers account for >50% of a key ingredient, an interruption can pause product lines for weeks.

• Currency Fluctuations: FX exposure and translation risk

• Implications: Limited natural hedges and cross-border sales expose margins to currency moves-monitor hedging policy disclosures.

• Economic Downturns: Consumer discretionary demand risk

Behavioral and financial sensitivity:

• Cosmetics are discretionary-historical downturn elasticity: consumer spend on cosmetics can decline 10%-25% in deep recessions.
• Revenue mix matters: prestige brands may show stickier demand than mass-market during mild slowdowns; private-label and price promotions increase.

Consolidated risk snapshot table:

For corporate context and strategic positioning, see: Mission Statement, Vision, & Core Values (2026) of Shanghai Chicmax Cosmetic Co., Ltd.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK) - Growth Opportunities

• Brand Expansion - Accelerate multi-brand strategy to capture adjacent segments (mass, premium, prestige). The China cosmetics market was approximately CNY 450 billion in 2023, leaving room for share gains by mid-sized players.
• E‑commerce Growth - Online channels now account for roughly 50-55% of beauty sales in China (2023 estimates). Scaling DTC stores, Tmall/JD flagship shops, and social commerce can materially improve gross margins and customer LTV.
• International Markets - The global beauty market was ~USD 500-520 billion in 2023. Exporting selective SKUs to Southeast Asia, the Middle East and APAC cross-border platforms can deliver higher ASPs and diversify FX exposure.
• Product Innovation - Faster SKUs rollout in high-growth categories (skincare serums, functional cosmetics, cosmeceuticals) can capture premiumization trends: anti-aging and clean-beauty niches grew faster than broader segments in 2022-23.
• Strategic Partnerships - Collaborations with influencers, cross-brand licensing, and retail partnerships (offline and omni-channel) reduce customer acquisition cost and speed market penetration.
• Sustainability Initiatives - Eco-packaging and ingredient traceability influence purchasing for an increasing share of urban consumers; sustainable claims can justify premium pricing and improve brand goodwill.

• Revenue Growth Scenarios (illustrative for Shanghai Chicmax, HKD/CNY mix):
• Conservative: 5% CAGR (2024-2027) - organic growth, maintain domestic share.
• Base: 12% CAGR (2024-2027) - e‑commerce expansion + 1-2 new sub-brands.
• Aggressive: 25% CAGR (2024-2027) - rapid brand launches, international roll-out, strategic JV/license deals.

• Key operational levers to monitor:
• Gross margin delta from online mix - target +3-7 percentage points.
• Customer acquisition cost (CAC) and repeat-purchase rate - improvements here drive unit economics.
• Export revenues as % of total - target incremental 10-20% within 3 years for diversification.
• R&D/product launch cadence - aim for 8-12 new SKUs annually in growth categories.